Abstract

Partnering in the Discovery & Development of Novel Biotherapeutics: A Perspective from Cancer Research UK

Robert Williams, Chief Development Scientist, Cancer Research UK

Cancer Research UK is the world’s largest charitable funder of cancer research. The organization has a long history of supporting the discovery and development of novel anti-cancer medicines. CRUK works extensively with academic institutes, biotechnology and pharmaceutical companies utilising a wide range of partnering arrangements and business frameworks. This presentation will describe examples of innovative collaborations in the discovery and development of new antibody-based therapeutics.